Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |